Source: International Congress 2017 – Animal models of asthma and allergies
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ramos-Barbon (Barcelona, Spain). Development of an innovative, Staphylococcus aureus enterotoxin B (SEB)-aided rat model of atopic asthma. 1152

Member's Comments

No comment yet.

Related content which might interest you: Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge Source: Eur Respir J, 55 (4) 1901592; 10.1183/13993003.01592-2019 Year: 2020 The functional role of IgE to staphylococcus aureus enterotoxins in severe asthma Source: International Congress 2019 – Understanding the mechanisms underlying airway diseases Year: 2019 The impact of sensitization to Staphylococcus aureus–derived enterotoxins on allergic and respiratory disorders Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Moulds and Staphylococcus aureus enterotoxins are relevant allergens to affect Type 2 inflammation and clinical outcomes in chronic rhinosinusitis patients Source: ERJ Open Res, 6 (4) 00265-2020; 10.1183/23120541.00265-2020 Year: 2020 Nasal polyposis and asthma: a mechanistic paradigm focusing on Staphylococcus aureus Source: Eur Respir Monogr 2017; 76: 122-137 Year: 2017 The effect of polyvalent mechanical bacterial lysate on the reduction of nasal Staphylococcus aureus carriage in children with pollen allergic rhinitis Source: International Congress 2019 – Asthma biomarkers, diagnostics and risk factors Year: 2019 An experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated piglets Source: Eur Respir J 2010; 36: 901-906 Year: 2010 What lessons have been learnt from animal models of MRSA in the lung? Source: Eur Respir J 2010; 35: 198-201 Year: 2010 Detection of alpha-hemolysin in Staphylococcus aureus derived respiratory strains: correlation with microbiological and clinical variables Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 Predictive factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a MRSA screening protocol. Source: International Congress 2018 – Difficult-to-treat respiratory infections Year: 2018 Time-dependent response of airway epithelial cells to Staphylococcus aureus Source: Eur Respir J 2004; 24: Suppl. 48, 555s Year: 2004 What is MRSA? Source: Eur Respir J 2009; 34: 1190-1196 Year: 2009 Human airway epithelial cell response to Pseudomonas aeruginosa virulence factors preceded or not by Staphylococcus aureus Source: Eur Respir J 2006; 28: Suppl. 50, 191s Year: 2006 The efficacies of macrolides in a murine model of methicillin-resistant staphylococcus aureus hematogenous pulmonary infection Source: Eur Respir J 2002; 20: Suppl. 38, 357s Year: 2002 Mechanisms of acquisition of resistance in Staphylococcus aureus Source: Annual Congress 2006 - Methicillin resistant Staphylococcus aureus (MRSA): a real hospital-based pathogen? Year: 2006 Risk factors for methicillin-resistant Staphylococcus aureus isolation from serially obtained sputum in patients hospitalized with pneumonia Source: Virtual Congress 2020 – Clinical challenges in pneumonia Year: 2020 Risk factors for MRSA staphylococcal carriage in children with chronic allergic diseases Source: Eur Respir J 2006; 28: Suppl. 50, 265s Year: 2006 Animal models of VAP Source: Eur Respir Mon 2011; 53: 98-112 Year: 2011 Prevalence and impact on FEV1 decline of methicillin-resistant Staphylococcus aureus infection in patients with cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011